High real-world effectiveness of 12-week elbasvir/grazoprevir without resistance testing in the treatment of patients with HCV genotype 1a infection in Norway
暂无分享,去创建一个
Carola Rosseland | R. Leiva | O. Dalgard | A. Finbråten | Ø. Simonsen | K. Hagen | M. Lagging | P. Sandvei | Ravinder Singh | R. S. Roberts | B. M. Bergersen | Lital Young | Yngve Mikkelsen